Cargando…
Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176010/ https://www.ncbi.nlm.nih.gov/pubmed/35847708 http://dx.doi.org/10.1002/jha2.78 |
| _version_ | 1784722570867638272 |
|---|---|
| author | Agrawal, Rohitashva Munker, Reinhold Krem, Maxwell M. |
| author_facet | Agrawal, Rohitashva Munker, Reinhold Krem, Maxwell M. |
| author_sort | Agrawal, Rohitashva |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9176010 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91760102022-07-14 Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL Agrawal, Rohitashva Munker, Reinhold Krem, Maxwell M. EJHaem Letters John Wiley and Sons Inc. 2020-08-12 /pmc/articles/PMC9176010/ /pubmed/35847708 http://dx.doi.org/10.1002/jha2.78 Text en © 2020 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters Agrawal, Rohitashva Munker, Reinhold Krem, Maxwell M. Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title | Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title_full | Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title_fullStr | Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title_full_unstemmed | Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title_short | Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL |
| title_sort | use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to cll |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176010/ https://www.ncbi.nlm.nih.gov/pubmed/35847708 http://dx.doi.org/10.1002/jha2.78 |
| work_keys_str_mv | AT agrawalrohitashva useofobinutuzumabforrefractoryautoimmunethrombocytopeniasecondarytocll AT munkerreinhold useofobinutuzumabforrefractoryautoimmunethrombocytopeniasecondarytocll AT kremmaxwellm useofobinutuzumabforrefractoryautoimmunethrombocytopeniasecondarytocll |